Dimensional Fund Advisors
OCRX

Dimensional Fund Advisors’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Dimensional Fund Advisors’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,648
Closed -$33K – 3317
2016
Q4 		$33K Hold
15,648
– – ﹤0.01% 3280
2016
Q3 		$41K Hold
15,648
– – ﹤0.01% 3261
2016
Q2 		$30K Hold
15,648
– – ﹤0.01% 3276
2016
Q1 		$46K Hold
15,648
– – ﹤0.01% 3268
2015
Q4 		$49K Buy
15,648
+3,107
+25% +$10.6K ﹤0.01% 3297
2015
Q3 		$40K Buy
12,541
+441
+4% +$1.7K ﹤0.01% 3345
2015
Q2 		$46K Hold
12,100
– – ﹤0.01% 3342
2015
Q1 		$57K Buy
+12,100
New +$69.7K ﹤0.01% 3304
2013
Q4 		– Sell
-1,300
Closed -$11K – 3545
2013
Q3 		$11K Buy
+1,300
New +$10.5K ﹤0.01% 3528

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors's OCRX Position: Q1 2017 in Review

Dimensional Fund Advisors sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 15,648 shares — an estimated $33K sold.

Dimensional Fund Advisors first reported a position in OCRX in Q3 2013 and held it in 9 quarters. The position peaked at $57K in Q1 2015. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

  • Dimensional Fund Advisors reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Dimensional Fund Advisors sold 15,648 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $33K.
  • Dimensional Fund Advisors first reported a position in Ocera Therapeutics, Inc. in Q3 2013 and held it in 9 quarters.
  • Dimensional Fund Advisors's Ocera Therapeutics, Inc. position peaked at $57K in Q1 2015.
  • 26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on Dimensional Fund Advisors's 13F filing for Q1 2017, filed 12 May 2017.